Abstract. To identify regions involved in tissue specific regulation of transcription of the a l (VI) collagen chain, transgenic mice were generated carrying various portions of the gene's 5'-flanking sequence fused to the E. coli 13-galactosidase gene. Analysis of the transgene expression pattern by X-gal staining of embryos revealed that: (a) The proximal 0.6 kb of promoter sequence activated transcription in mesenchymal cells at sites of insertion of superficial muscular aponeurosis into the skin; tendons were also faintly positive. (b) The region between -4.0 and -5.4 kb from the transcription start site was required for activation of the transgene in nerves. It also drove expression in joints, in intervertebral disks, and in subepidermal and vibrissae mesenchyme. (c) The fragment comprised within -6.2 and -7.5 kb was necessary for high level transcription in skeletal muscle and meninges. Positive cells in muscle were mostly mononuclear and probably included connective tissue elements, although staining of myoblasts was not ruled out. This fragment also activated expression in joints, in intervertebral disks, and in subepidermal and vibrissae mesenchyme. (d) [3-Galactosidase staining in vibrissae induced by the sequences -4.0 to -5.4 and -6.2 to -7.5 was not coincident: with the latter sequence labeled nuclei were found mainly in the ventral and posterior quadrant, and, histologically, in the outer layers of mesenchyme surrounding and between the follicles, whereas with the former the remaining quadrants were positive and expressing cells were mostly in the inner layers of the dermal sheath. (e) Other tissues, notably lung, adrenal gland, digestive tract, which produce high amounts of collagen type VI, did not stain for 13-galactosidase. (f) Central nervous system and retina, in which the endogenous gene is inactive, expressed the lacZ transgene in most lines. The data suggest that transcription of al(VI) in different tissues is regulated by distinct sequence elements in a modular arrangement, a mechanism which confers high flexibility in the temporal and spatial pattern of expression during development.
feature of the ECM is the preferred distribution of its components in different tissues and the peculiar variation of their expression during development (Adams and Watt, 1993) . Thus, in the embryo, the ECM can be considered as an array of signaling molecules which come in contact with distinct cell populations in a highly regulated manner and influence differentiation and morphogenesis (Lin and Bissel, 1993) . Several experiments in various vertebrate species and gene knock out of integrin receptors in the mouse support this view (DeSimone, 1994) .
The above considerations point out that a key question in the study of the different components of the ECM is how expression is regulated during development in vivo. Despite the very high number of ECM genes identified so far, data on their in vivo regulation are limited mostly to collagen type I (Pavlin et al., 1992; Liska et al., 1994; Rossert et al., 1995; Sokolov et al., 1995 ; references cited in these papers) and type II (Lovell-Badge et al., 1987; Horton et al., 1987) . In this report we extend this type of information to type VI collagen. This protein, a trimer of three different chains identified as etl(VI), 0t2(VI), and et3(VI), has a short collagenous domain flanked at both sides by a large globular domain composed of numerous von Willebrand factor type A repeats .
Collagen VI is adhesive for several cell types and interacts with a number of other extracellular molecules, like collagen type I, II, and III, biglycan, decorin, and hyaluronan (Bonaldo et al., 1990; Bidanset et al., 1992; Colombatti et al., 1993; Pfaff et al., 1993; Specks et al., 1992) , a property suggesting that the protein contributes to the ordered organization of the ECM. In the matrix, type VI collagen forms a network of microfibrillar aggregates distinct from, but often mixed with the banded fibers of type I collagen (Bruns et al., 1986) . Although the distribution of the two collagen types is widely overlapping, important differences have been described, including a high ratio of type VI to type I collagen in intervertebral disks and articular cartilage, and an opposite proportion in bone and a preferred localization of type VI collagen in the pericellular space or underneath epithelial cell layers (Keene et al., 1988; Marvulli et al., 1996) . These differences may be important for conferring peculiar mechanical properties not only to the various tissues, but also to distinct regions within the same tissue. An interesting difference between the two collagen types has also been revealed by studies on the in vitro differentiation of several cells of mesodermal origin, like adipocytes, myoblasts, and chondroblasts: collagen VI, but not I, is transiently expressed at very high levels during the initial phase of differentiation (Daniet al., 1989; Ibrahimi et al., 1993; Quarto et al., 1993; Piccolo et al., 1995) . To clarify the mechanisms responsible for tissue specific transcription of collagen type VI, we have undertaken the analysis of cis-acting elements of the cd(VI) chain gene in vivo. In this study we have identified genomic regions necessary for high level activation in several tissues.
Materials and Methods

DNA Constructs
The isolation and characterization of a h clone (mG1) for the mouse al(VI) collagen gene has been described . Two fragments of mG1 subcloned into the plasmid Bluescript (Stratagene, La JoUa, CA) were the starting material for the synthesis of the constructs used in this study. One SphI fragment contained N7.5 kb of the Y-flanking sequence of the gene, the first two exons, the first and part of the second intron, and included a PstI fragment extending from base +41 to base -1344 from the transcription start site . For synthesis of pl.41acZ, the 1.4-kb PstI fragment was inserted into the PstI site of pNSlacZ, a vector which contains the E. coil I$-galactosidase gene preceded by the nuclear localization signal and followed by the polyadenylation site of SV40 large T antigen between the Pstl and BamHI sites of pKS-Bluescript. A fragment extending from +75 to -635 was derived from the genomic clone by PCR amplification, restriction at the internal Pstl site, and insertion into pNSIacZ, producing plasmids p0.61acZ. To construct p7.5A(3.0-1.1)lacZ, the fragment extending from -7.5 to -3.0 kb was excised from the SphI subclone by cutting with NotI (in the polylinker) and NsiI and insetted into pl.41acZ after removal of the sequence upstream of the NsiI site at -1111 with the same enzymes. The NsiI fragment from -3.0 kb to base -1111 was then inserted into the Nsil site of p7.5A(3.0-1A)lacZ to give plasmid p7.51acZ. Constructs p6.21acZ, p5.41acZ, p4.01acZ, and p2.81acZ were derived by deleting 5' portions of p7.51acZ with restriction enzymes HindIII, BamHI, Sinai, and DraI, respectively ( Fig. 1 A) . Plasmids p7.5A(6.2-1.4)IacZ, p6.2A(5.4-1.4)lacZ, and p5.4A(4.0-1.4)lacZ (Fig. 1 B) were obtained by subcloning the appropriate restriction fragment in vector pl.41acZ upstream of the proximal 1.4 promoter region.
Production and Identification of Transgenic Mice
Transgenic mouse lines and embryos were produced from B6D2F1 females mated with B6D2F1 males (Charles River Italia or MBS, Treviso, Italy) using standard procedures (Hogan et al., 1986) . DNA was microinjected into pronuclei of one-cell embryos and the surviving embryos were implanted into CD1 pseudopregnant foster mothers. Transgenic mice were identified by analysis of genomic DNA from yolk sac or tail biopsies by either PCR using appropriate primers and reaction conditions or the dot blot assay. The number of integrated transgene copies of the lines was determined by Southern blot analysis using an internal fragment of lacZ as probe. To analyze the temporal and spatial pattern of [3-galactosidase expression in the established lines, founder or Fl-males were mated with B6D2F1 females and embryos isolated at different days of gestation. The day of the vaginal plug was designed day 0.5 of gestation. When the founder embryos were sacrificed the age was confirmed by staging (Butler and Juurlink, 1987) .
Whole Mount LacZ Staining and Histological Analysis
Embryos were dissected, quickly washed in PBS, and processed for fixation and histochemical staining for 13-galactosidase exactly as described (Bonnerot and Nicolas, 1993) . The dorsal part of 14.5 d and older embryos was cut with a razor blade on a midsagittal plane in order to facilitate penetration of fixative and staining solutions. After overnight incubation at 30°C in the staining solution, positive embryos were washed in PBS, photographed, fixed for 12-16 h in 4% paraforrnaldehyde in PBS, dehydrated in ethanol, and embedded in paraffin. 6-10-~m thick sections were mounted on gelatinized glass slides, counterstained with hematoxilin and eosin and mounted in Permount. All the pictures shown in this paper were from embryos excepting Figs. 4 C and 9 E, which were from the leg of an adult transgenic mouse. In this case the limb was disarticulated at the coxo-femoral joint and processed for X-gal staining after removal of the skin. The samples were then demineralized in 4% formic acid for one week and embedded in paraffin.
LacZ Staining and Immunofluorescence of Frozen Sections
Embryos were dissected in PBS and the left upper limb was cut out and individually processed for lacZ staining as described above. The rest of the embryo was frozen in isopentane cooled in liquid nitrogen and kept at -80°C. Transgertic embryos were identified the following day by inspection of the limbs. 6-10-p,m cryostat sections were collected on gelatincoated glass slides and air dried. For staining, the sections were fixed for 30 s in acetone, air dried, and incubated overnight in X-gal solution (Bonnerot and Nicolas, 1993) at room temperature. After washing in PBS, the slides were counterstained with hematoxilin and eosin and mounted in 50% glycerol in PBS. In some experiments sections stained for 13-galactosidase were treated with the mouse monoctonal antibody iC8 (Vitadello and Denis-Donini, 1990 ) which recognizes the NF-M subunit of mouse neurofilaments and/or a rabbit polyclonal antibody specific for mouse type VI collagen (Colombatti et al., 1995) . The slides were then incubated with rhodamine-labeled goat anti-mouse Ig and/or fluorescein-labeled goat anti-rabbit Ig, washed, stained with HOECHST dye, mounted in 50% glycerol in PBS and observed in a Zeiss Axioplan microscope equipped with epifluorescence optics.
Results
Generation of Transgenic Mice
Transgenic mice were generated with [3-galactosidase constructs comprising various portions of the 5'-flanking region of the txl(VI) collagen gene. For initial investigation of the pattern of promoter expression, a total of 34 independent expressing lines were generated using the constructs shown in Fig. 1 A. For most lines the founder was sacrificed; however, four lines with the longest and one with the shortest construct were propagated, allowing analysis of transgene expression at different developmental ages. No variations in the pattern and the intensity of Table I and Table II , respectively. transgene expression were observed in different embryos of the same established line. At least three lines were produced for each construct and, in each group, at least one line had multiple copies of the transgene (Table I) .
Expression of Transgenes
Embryos were whole mount-stained and examined. Serial sections were then prepared from each of them and observed in the microscope. For established transgenic lines, cryostat sections were also prepared and subsequently stained for [3-galactosidase. Similar results were obtained with the two procedures. The main distribution of 13-galactosidase-producing cells in tissues from the different lines is summarized in Table I in parallel with the evaluation of collagen VI expression products in control embryos at different locations (Marvulli et al., 1996) . Four major categories of tissues could be distinguished. In some tissues in which the synthesis of type VI collagen is very active, a particular construct was usually expressed or not expressed depending on the size of the promoter fragment. These tissues included skin insertions of superficial aponeurosis, joints, intervertebral disks, nerves, vibrissae, skeletal muscle, and meninges where expression was high, and tendons and subepidermal mesenchyme where the levels of activity of the reporter gene were usually weak. Expression in these tissues is described below in detail and is summarized in Table I . In a second group of tissues, 13-galactosidase staining was negative in most transgenic animals, although varying amounts of products (mRNA and protein) of the endogenous gene could be demonstrated in their connective tissue. This condition was detected in lung, digestive tract and associated glands, thymus, bladder, kidney, serosae, adrenal gland, gonads, periostium, and perichondrium. Examples of the absence of staining in these tissues can be found in Fig. 5 , D and E for stomach, adrenal gland, kidney and lung, and in Fig. 6 C for gonads and liver. Due to the absence of staining, these organs have not been considered in Table I . A third group comprised of tissues such as the central nervous system and the retina, which are not collagen VI producers, but which exhibited ectopic expression of the transgenes in almost every line or embryo investigated. A summary of this ectopic staining has been reported in Table I . Finally, some collagen VI-producing tissues randomly expressed the transgenes only in a limited set of lines (<20% of total) at low levels and with no apparent correlation with the size of the promoter sequence of the construct. Examples were heart, blood vessels, adipose tissue, and cartilage. Although not completely negative, the low expression of the transgenes in these tissues did not allow a clear analysis of the regulatory regions. These tissues were therefore not included in Table I . In the following description of 13-galactosidase expression in different tissues the emphasis will be on tissues of the first group. The pattern of expression in this group depended on the size of the regulatory region of the transgene. As this was increased, staining was found at additional sites, in such a way that tissues positive in transgenic mice with shorter constructs were usually a subgroup of those positive in animals with longer constructs (Table I) . Overall, there was a remarkable similarity in the pattern of expression of 13-galactosidase in lines with the same promoter construct. Variations were, however, observed in the levels of transgene expression between the lines, as estimated by the relative number of X-gal positive nuclei in a given tissue (Table I ). These differences were apparently not related to the transgene copy number and are likely a consequence of the site of DNA integration.
Sites of Insertion of the Superficial Muscular and Aponeurotic System. Constructs with a 5'-flanking region equal to or shorter than 4.0 kb (0.61acZ, 1.41acZ, 2.81acZ and 4.01acZ) gave very similar results (Table I and Fig. 2 ). In embryos of the line 0.61acZ57, [3-galactosidase reaction was detectable starting at 12.5 d as a ring in the limb buds, which was stronger in the forelimb (Fig. 2 A) . Discrete areas of staining were also noted just in front of the ear (Fig.  2 A) and at the armpit and the groin (Fig. 2 B) . Staining increased in intensity in the following days and, at 16.5 d, it was restricted to the forearm in the upper limb ( Fig. 2 C) , whereas, in the lower limb, it became a patch with posterior location (Fig. 2 D) . Embryos transgenic for the 1.41acZ, 2.81acZ, and 4.01acZ constructs produced a similar staining. Examples for 1.41acZ and 2.81acZ are shown in the Fig. 2 , E and F. The former was identical to the 0.61acZ line. The latter had a very strong reactivity in the ear region and, in addition, in the upper and lower eyelids. The staining pattern described above was common to all the transgenic embryos examined and examples with longer constructs can be seen in Figs. 3, 5 A, and 6 B. Microscopic examination revealed that all these positive, apparently unrelated, regions had a common histological motif, since they represented sites of insertion of the superficial aponeurosis which contains the cutaneous muscle (Fig. 3) . As explained in the Discussion, this tissue has been indicated in this study as the Superficial and Muscular Aponeurotic System (SMAS). The association of the od(VI) transgenes expression with this structure is clearly seen in the parasag- Control I 9.5 to 16.5 *Intensity of [3-galactosidase staining in each of the 34 lines was evaluated by examination of serial sections from whole mount stained embryos with the following arbitrary scale of stained nuclei: -, no labeled nuclei; ---, rare labeled nuclei at only a few locations; +, a few labeled nuclei at multiple locations or numerous labeled nuclei at a few locations; + +, numerous labeled nuclei at multiple locations or a few labeled nuclei at most locations or most nuclei labeled at a few locations; + + +, most nuclei labeled at multiple locations or numerous nuclei at most locations; + + + +, most nuclei labeled at most locations. For most lines, the founder was sacrificed at the indicated embryonic age. ~CNS, central nervous system. liThe founder was sacrificed at the indicated embryonic age. 1 Determined by immunohistochemistry and in situ hybridization experiments (Marvuni et al., 1996) . Arbitrary scale from no (-) to very intense (+ + + + ) staining.
ittal section of the hindlimb of Fig. 3 A, where the SMAS (arrows) inserted into the skin. At the insertion sites, mesenchymal cells accumulated very close to the epithelium and fibrillar structures from the connective tissue surrounding the superficial fascia converged toward them (Fig. 3 B) . A similar picture was detected in the armpit (Fig. 3 C) , and, in some embryos, in the eyelids (Fig. 3 D) . We interpret the latter localization as the site of anchorage of the palpebral connective tissue which envelops the orbicular ocular muscle to the conjunctiva and the skin of eyelids. An interesting detail of Fig. 3 D is that the cutaneous muscle converges toward the X-gal stained structures. The same organization was found in the region in front of the ear (Fig. 3 E) . In this case, however, 13-galactosidase staining accumulated where the superficial aponeurosis, rich in muscle fibers, intersected the ear cartilage. The proposed tissue architecture is illustrated in Fig. 3 F Embryo 2.81acZ1. Labeling is found in limbs, in a region in front of the ear and at the internal side of the root of the limbs (B, arrows) in all embryos, and, with lower frequency, in the eyelids (F). The capsules between the first and the second phalanges are also labeled in embryo 2.81acZ1 (F). Among this group of embryos, staining in phalanges was unique to 2.81acZ1.
in the tail were among the most reactive (Fig. 4 A) and labeled cells were found throughout their structure (data not shown). In other locations staining was mainly at the periphery of the tendon, in the peritenoneum (Fig. 4 B) , and at the bone-tendon junction. This was very clear in sections from adult animals, where the surface of insertion of tendon on bone was larger (Fig. 4 C) . All the sites expressing the transgene were strongly stained with antibodies to collagen VI (data not shown).
Joints and Intervertebral Disks. When the 5'-flanking region of the constructs was increased to 5.4-kb or to 6.2-kb, [3-galactosidase reaction became detectable in five additional tissues: joints, intervertebral disks, nerves, subepidermal mesenchyme, and vibrissae in all the lines (Table I) . These same tissues were positive in all lines with a regulatory sequence extending to -7.5 kb from the transcription start site [constructs 7.5A(3.0-1.1)lacZ and 7.51acZ] (Table I) and the data will therefore be presented in the same figures for all these constructs. Stain deposition in joints was particularly strong in articular cartilage of large diarthroses where it was apparent also in whole mount preparations when the superficial tissues were poorly labeled (Fig. 5 A) . Only a few cell layers underneath the articular surface were positive, whereas the bulk of cartilage was negative (Fig. 5, B and C) . Articular cartilage of small diarthroses was less frequently stained; this happened usually with longer constructs (Fig. 5 D) . In transgenic animals carrying the longest regulatory region, the synovial membrane was also stained (Fig. 5 C) . Intervertebral disks were among the tissues exhibiting highest reactivity (Fig. 5 E) .
Nerves. J3-Galactosidase staining associated with nerves was primarily studied in the mouse line 7.51acZ8, but the data were confirmed in all the embryos with constructs including the sequen.ce from -4.0 to -5.4. Faint labeling was first detectable as scattered groups of cells in the dorsal and lateral body wall and in the proximal part of the upper limb at 11.5 d (data not shown). One day later, the reaction was stronger and appeared as a superficial network which extended ventrally with a sharp border in the body wall, reached the forearm in the upper limb and began to expand into the lower limb (Fig 6 A) . In the following days the network invaded completely the ventral region and propagated to the tip of the fingers (Fig. 6 B) . The neck (Fig. 6, A and B) was also stained. In the head, labeling was weaker and was slightly enhanced in the temporal and in the frontal regions (data not shown). The identity of the observed structures as nerves was established by histological analysis of serial sections (Fig. 6, C (Fig. 6 E) . Additional information on the location of the labeled cells with respect to the axon bundles was obtained by staining the same cryostat section histochemically for ~-galactosidase and immunologieally with antibodies specific for neurofilaments and type VI collagen (Fig. 7) . Reactive cells were found in contact with axon bundles of different sizes (Fig. 7, A and C) . In larger axon associations the cells were almost exclusively detected at the periphery. This is particularly evident in Fig.  7 , C, D, and E, which show an oblique section of a nerve: on the left side, where the innermost part of the nerve has been sampled, labeled nuclei border the axon bundle; on the right side, where the section cuts the nerve tangentially, stained nuclei overlap with a region immunofluorescent for neurofilaments and strongly positive for collagen type VI.
Vibrissae and Subepidermal Mesenchyme. Mesenchymal cells surrounding vibrissae were positive in embryos with promoter fragments larger than 4.0 kb (Table I; Figs. 5 A, 6 B, 8 A, and 9 A). In addition, two out of seventeen lines with the promoter region shorter than 4.0 kb also had staining in this tissue (lines 2.81acZ1 and 4.01acZ3). It is worth noting that both lines had multiple copies of the transgene. X-gal positive cells were found in the loose connective tissue under the skin. The nature of these cells is unknown and, given their fibroblast-like morphology, they can be generally classified as mesenchymal cells. Staining of this subepidermal mesenchyme was apparent only relatively late (after 14.5-15.5 d of gestation) and was faint in most embryos, excepting those of the 7.51acZ8 line, in which labeled nuclei were more abundant in the subcutaneous tissue; in the dermis positive cells were often close to hair follicles (Fig. 8 B) .
Skeletal Muscle. Transgenic embryos generated with constructs including the entire 7.5-kb of 5'-flanking sequence (7.51acZ) or a fragment with an internal deletion in the 3' region [7.5A(3.0-1.1)lacZ], expressed 13-galactosidase at high levels in the tissues described above (Table I ). In addition, positive cells were found in skeletal muscle, particularly in the two lines 7.51acZ8 and 7.51acZ62. Very faint staining with a metameric pattern was first detectable in whole mount preparations of ll.5-d embryos in the dorsolateral region (data not shown). At 13.5 d, strongly reactive muscle masses were located in the lateral body wall (Fig. 9 A) , in the dorsal region as a long thread bordering the vertebral column (Fig. 9 B) , and in the limbs (Fig. 9, A and B) . Histological examination revealed that different muscles stained with different intensity (Fig. 9 C and Fig. 6 E) . Interestingly, however, the pattern of muscle labeling was similar in the various lines and embryos (compare Fig. 9 C with Fig, 6 C) . At high microscopic magnification, it was apparent that 13-galactosidase reaction was predominant in mononuclear cells surrounding the muscle fibers (Fig. 9 D) . Very often it could not be established if the labeled nuclei belonged to the mononuclear cells or to the myotubes. Thus, we cannot exclude at the moment the possibility that the transgenes were expressed by the muscular elements. X-gal positive nuclei were also detected in adult muscle (Fig. 9 E) . Most nuclei were clearly located within the connective tissue; however, some were very flat and closely associated with the myofibers in a way expected for nuclei of the myotubes or of satellite cells. Staining in skeletal muscle was also detected in ~1 5 % of the lines with the promoter fragment not including the region -6 . 2 to -7.5 (Table I) .
Meninges. Lines with a transgene containing the region from -7.5 to -6 . 2 exhibited expression in meninges. With shorter constructs only two embryos showed labeled meninges, one of which had a high transgene copy number (Table I) . A n example of labeling of meninges can be seen in Fig. 9 C. Ectopic Expression. The central nervous system and/or the retina, which are not collagen VI producers, were reactive for 13-galactosidase in 32 out of 34 transgenic lines (Table I ). In the central nervous system staining was usually detected in the telencephalon and in the spinal cord. Examples of staining in the central nervous system and retina can be found in Figs. 2 A, E, F, 5 E, 9, A and B. nine tissues where type VI collagen is normally expressed, including insertion of superficial aponeurosis, tendons, joints, intervertebral disks, nerves, subepidermal mesenchyme, vibrissae, skeletal muscle, and meninges. Excepting the first two, the elements for the other seven tissues are apparently located in the region -4.0 to -7.5. The analysis of Table I , however, does not tell us if different portions of this large region are equally effective as inducers. In addition, for some other tissues, notably skeletal muscle and meninges, 13-galactosidase expression was always present with the longest constructs, but was also observed at low frequency in transgenic lines with shorter constructs. These results cannot distinguish between a model which localizes the active sequence in the far upstream region and models which consider the more frequent expression in the longest constructs as a consequence either of promoter insulation by the larger DNA fragment or of a scattered distribution of weak activating elements. To throw light on these issues, 23 transgenic lines were produced with the constructs delineated in Fig. 1 chyme was present in the -4.0 to -5.4 and -6.2 to -7.5 sequences, but was absent in the -5.4 to -6.2 fragment.
Further Analysis of the Promoter Region from
Interestingly, staining differed between the two constructs 5.4A(4.0-1.4)lacZ and 7.5A(6.2-1.4)lacZ. In 7.5A(6.2-1.4)lacZ lines strongly positive vibrissae were located in the ventral-posterior quadrant (Fig. 10 A) . This same area was poorly stained in the 5.4A(4.0-1.4)lacZ lines, in which labeling was detected in the remaining quadrants (Fig. 10  B) . Significant differences were also observed at the histological level: in 7.5A(6.2-1.4)lacZ lines X-gal labeled nuclei were more abundant in the outer layers of the dermal sheath and in the mesenchyme between follicles (Fig. 10  C) , whereas in 5.4A(4.0-1.4)lacZ lines [3-galactosidase positive cells were almost exclusively found in the inner layers of the dermal sheath and in the dermal papilla (Fig. 10 D) . 
Discussion
The main conclusion suggested by the experiments presented in this study is that the transcriptional activation of the od(VI) collagen gene in different tissues during embryonic development is regulated by multiple cis-acting elements scattered over several kilobases of genomic sequence. The region analyzed extends from the transcription start site to 7.5 kb upstream and contains sequence information for expression in several collagen VI producing tissues, including sites of insertion of superficial and muscular aponeurosis, tendons, joints, intervertebral disks, nerves, subepidermal mesenchyme, vibrissae, skeletal muscle, and meninges. This is only a subset of the organs which express type VI collagen in their connective tissue (Marvulli et al., 1996) . Thus, transgenes were not active in the mesenchyme of the digestive tract and the adjacent glands, in the lung, in the kidney, in the cornea, in the periostium and perichondrium, in the gonads, and in the adrenal glands. Our suggestion is that, in all these organs, transcription is dependent on regulatory sequences not included in the DNA genomic fragment studied here. Preliminary experiments in which we have extended our analysis to the region from -7.5 to -14.0 kb confirm this conclusion: the addition of this region apparently activates [3-galactosi- *The region -4.0 to -7.5 was studied producing transgenic animals with the three constructs defined in Fig. 1 B. The founder animals were sacrificed at the embryonic age indicated and analyzed for ~-galactosidase expression as detailed in footnote* of Table I . ~Determined by immunohistochemistry and in situ hybridization experiments (Marvulli et al., 1996) . Arbitrary scale from no (-) to very intense (+ + + +) staining.
dase expression in several other tissues, including lung, digestive tract, and cornea (Braghetta, P., manuscript in preparation). On the other hand, transgenes were expressed in the central nervous system and in the retina, tissues where collagen VI was not detected (Marvulli et al., 1996) . Ectopic induction of transgenes in the central nervous system has been observed with promoters for type I collagen chains (Niederreither et al., 1992; Rossert et al., 1995; Sokolov et al., 1995) . In experiments comparable to those described here, however, a much lower frequency in different lines has been reported (~30%: Niederreither et al., 1992) compared to ours (~95%). The reason for this high frequency of activation is not known; one possibility is that negatively acting elements normally suppress transcription of etl(VI) in the central nervous system and retina and that these sequences are not contained in the promoter fragments we have studied.
As for the collagen VI-producing tissues where the transgenes were expressed with high frequency, analysis of Tables I and II suggests the following conclusions on the transcriptional regulation of al(VI) (summarized in Fig. 11 ).
(A) In all the transgenic lines examined expression was active at low levels in tendons and, at high levels, in discrete areas of the limb buds, in the armpit and the groin and in front of the ear. The latter distribution of 13-galactosidase staining was rather odd, being detected in apparently unrelated locations. Careful histological analysis, however, revealed staining of cells at the sites of insertion of the superficial and muscular aponeurosis as a common motif. These sites were the skin and the ear cartilage. The superficial aponeurosis is a fibrous connective tissue which divides the subcutaneous tissue into a superficial and a deep layer (see Fig. 3 F) . In most mammals it contains skeletal muscle fibers, the cutaneous muscles (see Fig. 8 B) , also known as panniculus carnosus, which have the function to move the skin. In human, this tissue has been very well studied and has been designated SMAS (Mitz and Peyronie, 1976) , a term which has been adopted here also for the mouse to stress its fascial (aponeurotic) nature. Human SMAS does not contain muscle in most body locations except in the face where it envelops the facial muscles, which are important in determining the characteristic expression of each person. It is worth noting that the human SMAS of the face attaches posteriorly to the tragus and penetrates anteriorly into the fibers of the orbicular muscle of the eye. The corresponding locations of mouse embryos contained cells expressing the transgenes at high levels. Our immunohistochemical results (Marvulli et al., 1996) indicate that collagen type VI is particularly abundant at the sites of insertion of SMAS. The surrounding dermis, however, contains collagen VI too. This situation may explain why this particular area of collagen type VI deposition has not been noted previously.
Positively acting elements for insertion of SMAS and Figure 11 . Summary of the distribution of regulatory regions controlling tissue-specific expression of the al(VI) collagen gene. Only regions producing high frequency X-gal staining in the different transgenic lines are indicated. For a particular promoter region, tissues in which 13-galactosidase expression was strong (see scale in Table I ) are in bold letters. Arrow indicates the transcription initiation site of the gene; El, E2, first, and second exon. The sequence examined in this study is represented by the continuous thick line. S.A., superficial aponeurosis; i.v. disks, intervertebral disks.
tendons are contained within the first 600 bp upstream of the transcription start site. In fact, all the lines generated expressed the reporter gene in these tissues and the 600-bp are the only promoter sequence common to the different transgenes. A confirmation of this conclusion comes from recent experiments on the production of transgenic lines with lacZ constructs similar to those of Fig. 1 B in which the 1.4-kb fragment of the ed(VI) promoter has been substituted by the human B-globin basal promoter (55 bp). Preliminary data have shown that a B-globin construct containing the fragment -4.0 to -5.4 of the cd(VI) promoter had a tissue pattern of expression equivalent to the corresponding 5.4A(4.0-1.4)lacZ constructs with the exception of insertions of SMAS and tendons, where expression was missing (Braghetta, P., unpublished results).
(B) Transcriptional induction in joints, intervertebral disks, subepidermal mesenchyme, and nerves was absolutely dependent on sequences located upstream of -4.0. The data reported in Table II indicate that the region from -4.0 to -7.5 contains more than one c/s-activating sequence for joints, intervertebral disks, and subepidermal mesenchyme. In particular, one element(s) is located between -4.0 and -5.4 and a second element(s) between -6.2 and -7.5. In addition, a third element(s) with low activity for joints and intervertebral disks may be contained in the fragment -5.4 to -6.2, since one of the two 6.2A(5.4-1.4)lacZ lines with multiple transgene copies exhibited ~-galactosidase expression.
On the other hand, sequences responsible for expression in nerves were restricted to the region -4.0 to -5.4. Potential cell types expressing the transgenes include Schwann cells, fibroblasts, and perineurial cells, all of which have been shown to produce type VI collagen in human (Peltonen et al., 1990) . Preliminary experiments from our laboratory have revealed that the X-gal positive cells in nerves stain for markers of peripheral glia, suggesting that they likely belong to the Schwann cell lineage (Vitale, P., manuscript in preparation). At the moment, however, we cannot exclude the possibility that fibroblasts and perineurial cells also express the transgene. The existence of cis-acting elements regulating specific transcription of the ed(VI) collagen chain in nerves suggests a special role of type VI collagen in this tissue. Given the early stage of activation of the transgene (11.5-d embryo) and the rapid increase of its expression, one attractive hypothesis is that collagen VI favors the initial morphogenesis of the nerves.
(C) Expression of the transgenes in the mesenchyme of vibrissae was strongly dependent on the regions -4.0 to -5.4 and -6.2 to -7.5. However, expression at low frequency was also observed with constructs 2.81acZ (1 in 4 lines) and 4.01acZ (1 in 7 lines). The interpretation of this result is that either transcription was induced by the particular site of insertion of the transgene in these lines or the region between -1.4 and -4.0 comprises positive regulatory sequences with low activity. The latter interpretation seems more likely, since the two expressing lines have multiple copies of the transgene, a condition which favors expression of weak promoters. Transcription in different domains of the area of vibrissae and of different layers of mesenchyme around the follicles are dependent mainly on two distinct promoter regions. This finding suggests an unexpected complexity in the cell population of this mesenchyme. Expression of different transgenes may therefore be considered a useful marker for the characterization of the two cell groups.
(D) Strong activating sequences for skeletal muscle and meninges were present in the fragment -6.2 to -7.5. Considerations similar to those discussed under C for vibrissae lead to the conclusion that additional weak stimulatory sequences may be located also outside this fragment. The exact position of the elements is difficult to identify, due to the low frequency and low level of X-gal staining with constructs lacking the region -6.2 to -7.5. As for muscle, the sporadic expression could be accounted for by the presence of a single weak element within -1 and 600 bp, but other possibilities cannot be ruled out. In the case of meninges, the minimum number of weak activating sequences deduced from the experiments is two, one between -1.4 and -2.8, the other between -4.0 and -5.4.
Collagen VI is produced in high quantities in skeletal muscle, where it is deposited very close to the surface of the myotubes (Marvulli et al., 1996) . Collagen VI expression by myoblasts in vitro is low in the logarithmic phase of proliferation, increases quickly when subconfluent cells are induced to differentiate and declines before myotubes appear (Piccolo et al., 1995) . Assuming that myoblasts in vivo have the same behavior, one would expect that high transgene expression will be detectable in myoblasts just before fusion, will become very low in fusing myoblasts, and will be absent in fully developed myotubes. Since, as reported for other systems, [3-galactosidase is an appropriate reporter gene to follow the temporal expression of a promoter during development (Sham et al., 1993) , staining should be found frequently in mononuclear cells, while 13-galactosidase activity should be almost undetectabie in myotubes. This expected expression pattern of the etl(VI) promoter precludes a clear identification of the cells producing the transgene based on morphological data only. To settle this issue will require labeling with probes for specific markers of myoblasts. Characteristically, the expression levels of the transgenes varied in different mus-cles. This variation was not random, since the pattern of relative intensity was similar in the various positive mouse lines. Since no such differences could be detected in the expression of the endogenous ctl(VI) gene by in situ hybridization and immunohistochemistry (Marvulli et al., 1996) , it should be concluded that the 7.5-kb of regulatory sequence analyzed here contains only partial information for transcriptional activation in skeletal muscle.
Since type VI collagen is widely distributed and found in most connective tissues, one would expect a simpler regulation of its genes. However, a thorough analysis of type VI collagen products during development has unveiled an elaborate pattern of expression (Marvulli et al., 1996) . For example, the mRNA steady-state levels are first detectable in the various tissues at different stages and show different dynamics in embryonic and postnatal life; moreover, at variance with type I collagen, the abundance of both mRNA and protein in the connective tissues underneath epithelia is not homogeneous, but decreases with the distance from the basement membrane. Complex patterns of expression have been described for other proteins of the extracellular matrix, but information on their transcriptional regulation is usually limited. An exception is type I collagen, for which numerous studies on promoter activity in transgenic animals are available ( 
